BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 21953630)

  • 1. Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer.
    Ilie M; Hofman V; Ortholan C; Bonnetaud C; Coëlle C; Mouroux J; Hofman P
    Cancer; 2012 Mar; 118(6):1726-37. PubMed ID: 21953630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection.
    Li YW; Qiu SJ; Fan J; Zhou J; Gao Q; Xiao YS; Xu YF
    J Hepatol; 2011 Mar; 54(3):497-505. PubMed ID: 21112656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated neutrophils and macrophages in non-small cell lung cancer: no immediate impact on patient outcome.
    Carus A; Ladekarl M; Hager H; Pilegaard H; Nielsen PS; Donskov F
    Lung Cancer; 2013 Jul; 81(1):130-7. PubMed ID: 23540719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma.
    Jensen HK; Donskov F; Marcussen N; Nordsmark M; Lundbeck F; von der Maase H
    J Clin Oncol; 2009 Oct; 27(28):4709-17. PubMed ID: 19720929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
    Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.
    Al-Shibli KI; Donnem T; Al-Saad S; Persson M; Bremnes RM; Busund LT
    Clin Cancer Res; 2008 Aug; 14(16):5220-7. PubMed ID: 18698040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
    Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
    Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 promotes progression of non-small cell lung cancer.
    Sienel W; Dango S; Woelfle U; Morresi-Hauf A; Wagener C; Brümmer J; Mutschler W; Passlick B; Pantel K
    Clin Cancer Res; 2003 Jun; 9(6):2260-6. PubMed ID: 12796394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer.
    Kobayashi N; Usui S; Kikuchi S; Goto Y; Sakai M; Onizuka M; Sato Y
    Lung Cancer; 2012 Feb; 75(2):223-7. PubMed ID: 21764477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of low vascular endothelial growth factor A (VEGF-A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor in patients with nonsmall cell lung cancer.
    Donnem T; Al-Shibli K; Andersen S; Al-Saad S; Busund LT; Bremnes RM
    Cancer; 2010 Sep; 116(18):4318-25. PubMed ID: 20549821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM-1) is associated with increased angiogenic potential in non-small-cell lung cancer.
    Dango S; Sienel W; Schreiber M; Stremmel C; Kirschbaum A; Pantel K; Passlick B
    Lung Cancer; 2008 Jun; 60(3):426-33. PubMed ID: 18215438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer.
    Rakaee M; Busund LT; Paulsen EE; Richardsen E; Al-Saad S; Andersen S; Donnem T; Bremnes RM; Kilvaer TK
    Oncotarget; 2016 Nov; 7(44):72184-72196. PubMed ID: 27708229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized peptide vaccination in patients with refractory non-small cell lung cancer.
    Yoshiyama K; Terazaki Y; Matsueda S; Shichijo S; Noguchi M; Yamada A; Mine T; Ioji T; Itoh K; Shirouzu K; Sasada T; Takamori S
    Int J Oncol; 2012 May; 40(5):1492-500. PubMed ID: 22307435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03.
    Teramukai S; Kitano T; Kishida Y; Kawahara M; Kubota K; Komuta K; Minato K; Mio T; Fujita Y; Yonei T; Nakano K; Tsuboi M; Shibata K; Furuse K; Fukushima M
    Eur J Cancer; 2009 Jul; 45(11):1950-8. PubMed ID: 19231158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
    Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
    Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma.
    Jensen TO; Schmidt H; Møller HJ; Donskov F; Høyer M; Sjoegren P; Christensen IJ; Steiniche T
    Cancer; 2012 May; 118(9):2476-85. PubMed ID: 21953023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The favorable prognostic significance of atelectasis in patients with advanced non-small cell lung cancer: results of a prospective observational study.
    Dediu M; Crisan E; Radut M; Tarlea A; Median D; Alexandru A; Vremes G; Gal C
    Lung Cancer; 2009 Feb; 63(2):271-6. PubMed ID: 18565617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
    Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis.
    Pelletier MP; Edwardes MD; Michel RP; Halwani F; Morin JE
    Can J Surg; 2001 Jun; 44(3):180-8. PubMed ID: 11407827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.